Saturday, July 11, 2026

Drug profile · INN

chlorphentermine hydrochloride

chlorphentermine hydrochloride (PRE-SATE) is a serotonin transporter substrate. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — chlorphentermine hydrochloride
US status
approved
Class
Route
ORAL
Patents
0
Programs
1
Data quality
0.84

Quick answer

chlorphentermine hydrochloride (PRE-SATE) is a serotonin transporter substrate. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN chlorphentermine hydrochloride
Brand PRE-SATE
Mechanism Serotonin transporter substrate
Target Sodium-dependent serotonin transporter
Route ORAL
Formulation TABLET

Mechanism of action

Serotonin transporter substrate

Primary target: Sodium-dependent serotonin transporter

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Phentermine Unknown · Takeda · Obesity

Related & competitor drugs

  1. citalopram hydrobromide Serotonin transporter inhibitor
  2. clomipramine hydrochloride Serotonin transporter inhibitor
  3. escitalopram oxalate Serotonin transporter inhibitor
  4. fluoxetine hydrochloride Serotonin transporter inhibitor
  5. fluvoxamine maleate Serotonin transporter inhibitor
  6. paroxetine hydrochloride Serotonin transporter inhibitor

Frequently asked questions

What is chlorphentermine hydrochloride?

chlorphentermine hydrochloride (PRE-SATE) is a serotonin transporter substrate. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for chlorphentermine hydrochloride?

PRE-SATE is a marketed brand name for chlorphentermine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of chlorphentermine hydrochloride?

chlorphentermine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.